{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:24:42Z","timestamp":1773109482488,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1053\/j.ajkd.2008.01.013","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T10:12:29Z","timestamp":1206094349000},"page":"732-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans"],"prefix":"10.1053","volume":"51","author":[{"given":"Janice","family":"Lea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Cheek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Thornley-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Agodoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gassman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Lash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Edgar R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otelio","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.01.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.01.013_bib2","series-title":"USRDS 2003 Annual Data Report","year":"2003"},{"key":"10.1053\/j.ajkd.2008.01.013_bib3","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.01.013_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American Study of Kidney Disease and Hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib5","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.01.013_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.01.013_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.01.013_bib9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.01.013_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.01.013_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(98)01346-4","article-title":"Pathogenesis, prevention, and treatment of diabetic nephropathy","volume":"352","author":"Cooper","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.01.013_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(12)70230-5","article-title":"Obesity-associated focal segmental glomerulosclerosis: Pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia","volume":"20","author":"Verani","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.01.013_bib15","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1097\/01.ASN.0000141965.28037.EE","article-title":"Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease?","volume":"15","author":"Bagby","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.01.013_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.ajkd.2005.08.015","article-title":"Association between body mass index and CKD in apparently healthy men","volume":"46","author":"Gelber","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.01.013_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib18","first-page":"137","article-title":"Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus","volume":"19","author":"Walker","year":"1993","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/j.ajkd.2008.01.013_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000187210","article-title":"Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency","volume":"63","author":"Samuelsson","year":"1993","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2008.01.013_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: A meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.01.013_bib21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am J Hypertens"},{"issue":"suppl 9","key":"10.1053\/j.ajkd.2008.01.013_bib22","first-page":"S52","article-title":"Effects of ACE inhibitors and calcium channel blockers on insulin sensitivity and other components of the syndrome","volume":"10","author":"Sowers","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.01.013_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00392-007-0571-3","article-title":"Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure","volume":"97","author":"Kovacic","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"10.1053\/j.ajkd.2008.01.013_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/080370599439463","article-title":"Beta-blocking agents in patients with insulin resistance: Effects of vasodilating beta-blockers","volume":"8","author":"Jacob","year":"1999","journal-title":"Blood Press"},{"key":"10.1053\/j.ajkd.2008.01.013_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1053\/j.ajkd.2008.01.013_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/diacare.26.3.575","article-title":"A comparison of the prevalence of the metabolic syndrome using two proposed definitions","volume":"26","author":"Ford","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2008.01.013_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","article-title":"Hypertension and associated metabolic abnormalities\u2014The role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"N Engl J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:49:02Z","timestamp":1759456142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0272638608000656"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.01.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}